Institutions / Tetragon Partners GP Ltd
Tetragon Partners GP Ltd
CIK 1515070 · Institution · as of Dec 31, 2025
Portfolio value
$474.27M
Positions
28
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 28 →
| Company | Value | % of portfolio |
|---|---|---|
| UiPath, Inc. | $286.01M | 60.3% |
| Kolibri Global Energy Inc | $27.25M | 5.7% |
| Lyft, Inc. | $19.37M | 4.1% |
| Autolus Therapeutics plcAUTL | $18.91M | 4.0% |
| Sprinklr, Inc. | $17.12M | 3.6% |
| Workiva Inc | $12.94M | 2.7% |
| Annexon, Inc. | $10.20M | 2.2% |
| Praxis Precision Medicines, Inc. | $6.76M | 1.4% |
| Celldex Therapeutics, Inc. | $6.62M | 1.4% |
| Arrowhead Pharmaceuticals, Inc. | $6.44M | 1.4% |
| Pharvaris N.V. | $5.40M | 1.1% |
| Axsome Therapeutics, Inc. | $4.92M | 1.0% |
| Dyne Therapeutics, Inc. | $4.85M | 1.0% |
| MBX Biosciences, Inc.MBX | $4.52M | 1.0% |
| Rapt Therapeutics Inc | $4.46M | 0.9% |
| Agios Pharmaceuticals, Inc. | $4.41M | 0.9% |
| Immunovant, Inc.IMVT | $4.22M | 0.9% |
| Alkermes plc. | $3.95M | 0.8% |
| Amicus Therapeutics Inc | $3.71M | 0.8% |
| Amylyx Pharmaceuticals, Inc. | $3.30M | 0.7% |
| Harmony Biosciences Holdings Inc | $3.10M | 0.7% |
| Nektar Therapeutics | $2.93M | 0.6% |
| Krystal Biotech, Inc. | $2.91M | 0.6% |
| Maplight Therapeutics IncMPLT | $2.89M | 0.6% |
| Silence Therapeutics plcSLN | $2.22M | 0.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.